Topic

Pennsylvania

A collection of 524 issues

How to Get Orladeyo (berotralstat) Covered by UnitedHealthcare in Pennsylvania: Complete Guide to Prior Authorization, Appeals, and State Protections

Quick Answer: Getting Orladeyo Covered in Pennsylvania Fast track to approval: Submit prior authorization through UnitedHealthcare's provider portal with complete HAE diagnosis documentation, C1-INH lab results, and evidence of failed/contraindicated injectable therapies. If denied, you have 180 days for internal appeals, then 4 months for Pennsylvania'
6 min read

Lowering Out-of-Pocket Costs for Fintepla with UnitedHealthcare in Pennsylvania: Complete Copay, Tiering & Financial Assistance Guide

Answer Box: Getting Fintepla Covered by UnitedHealthcare in Pennsylvania Fintepla (fenfluramine) requires prior authorization from UnitedHealthcare and is placed on Specialty Tier 5 with high out-of-pocket costs. To minimize expenses: 1) Apply for UCB's ONWARD Copay Assistance Program (can reduce copays to $0-$25 for commercial insurance), 2)
5 min read

How to Get Keytruda (Pembrolizumab) Approved by UnitedHealthcare in Pennsylvania: Complete Timeline and Appeals Guide

Quick Answer: Getting Keytruda Covered by UnitedHealthcare in Pennsylvania UnitedHealthcare requires prior authorization for Keytruda (pembrolizumab) in Pennsylvania, typically taking 5-14 business days for standard review. You'll need biomarker testing (PD-L1, MSI-H, or TMB-H), complete staging documentation, and evidence of medical necessity aligned with NCCN guidelines. If denied,
5 min read

How to Get Dupixent (dupilumab) Covered by UnitedHealthcare in Pennsylvania: Prior Authorization, Appeals, and Alternative Options

Answer Box: Getting Dupixent Covered by UnitedHealthcare in Pennsylvania UnitedHealthcare requires prior authorization for Dupixent (dupilumab) in Pennsylvania, with a 72-hour review timeline. Most approvals require documented diagnosis, prior therapy failures, and specialist prescription. If denied, you have 180 days for internal appeals, then 4 months for Pennsylvania's
5 min read

How to Get Filspari (sparsentan) Covered by Blue Cross Blue Shield in Pennsylvania: Prior Authorization Guide and Appeals Process

Quick Answer: Getting Filspari Covered by Blue Cross Blue Shield in Pennsylvania Filspari (sparsentan) requires prior authorization from Blue Cross Blue Shield plans in Pennsylvania. You'll need: confirmed IgA nephropathy diagnosis via kidney biopsy, documented REMS enrollment, quarterly liver function tests, and evidence of failed ACE inhibitor/ARB
6 min read

Get Firazyr (icatibant injection) Covered by Cigna in Pennsylvania: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Firazyr Covered by Cigna in Pennsylvania Firazyr (icatibant injection) requires prior authorization from Cigna for hereditary angioedema (HAE) treatment. Fastest path to approval: Have your HAE specialist submit a complete PA request with confirmed HAE diagnosis (low C1-INH levels), documented attack history, and specialist consultation notes. Cigna
5 min read

Getting Gamifant (Emapalumab) Covered by Humana in Pennsylvania: Complete Guide with Forms and Appeals Process

Quick Answer: Getting Gamifant Covered by Humana in Pennsylvania Yes, Humana covers Gamifant (emapalumab-lzsg) with prior authorization for primary HLH. The fastest path: Your hematologist submits a PA request via fax (502-508-9300) with HLH-2004 diagnostic criteria, conventional therapy failure documentation, and infection screening results. Standard approval takes 7-30 days; expedited
6 min read

Do You Qualify for Revcovi (Elapegademase) Coverage by Humana in Pennsylvania? Complete Decision Tree & Appeals Guide

Quick Answer: Revcovi Coverage by Humana in Pennsylvania Eligibility: You likely qualify if you have confirmed ADA-SCID with biochemical or genetic testing showing adenosine deaminase deficiency below 1% of normal. Fastest path: Have your immunologist submit prior authorization with ADA enzyme activity results, genetic testing, and medical necessity letter through
6 min read